Venlafaxine vs. fluoxetine in postmenopausal women with major depressive disorder: an 8-week, randomized, single-blind, active-controlled study

BACKGROUND: In the population of postmenopausal patients with major depressive disorder (MDD), the superiority of serotonin-norepinephrine reuptake inhibitors (SNRIs) over selective serotonin reuptake inhibitors (SSRIs) has not yet been definitively proven. Consequently, a direct comparison of the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Jingjing, Wang, Xiao, Feng, Lei, Xiao, Le, Yang, Rui, Zhu, Xuequan, Shi, Hui, Hu, Yongdong, Chen, Runsen, Boyce, Philip, Wang, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135153/
https://www.ncbi.nlm.nih.gov/pubmed/34011310
http://dx.doi.org/10.1186/s12888-021-03253-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135153/
https://www.ncbi.nlm.nih.gov/pubmed/34011310
http://dx.doi.org/10.1186/s12888-021-03253-8

Ejemplares similares